SERMORELIN 5MG: SMOOTH GROWTH HORMONE RELEASING PEPTIDE

Description

Legal Disclaimer
This information has not been reviewed or endorsed by the US FDA. It is provided solely for educational and research purposes. Sermorelin is not approved for medical use, human consumption, or as a therapeutic treatment in this context.

Product Details

• Quantity: 10mg per vial

• Form: Lyophilized peptide powder

• Packaging: Secure, sealed, and tamper-proof sterile vial

• Source: High-quality lab-grade peptide, independently third-party tested

• Purity: ≥98% verified by HPLC and mass spectrometry

• Note: This product is sold in powder form and must be reconstituted prior to laboratory use

Overview of Sermorelin’s Research Profile

Sermorelin is a synthetic peptide analog corresponding to the first 29 amino acids of growth hormone–releasing hormone (GHRH 1-29). It is extensively studied in laboratory environments for its role in stimulating endogenous growth hormone release via activation of GHRH receptors in the pituitary signaling pathway.

Unlike direct growth hormone analogs, Sermorelin is researched for its ability to initiate physiological GH signaling cascades, making it a valuable tool for studying regulated endocrine feedback mechanisms. Its short activity window and receptor specificity allow researchers to model pulsatile hormonal signaling and hypothalamic–pituitary communication with high precision.

Research Specifics

Sermorelin has been investigated in non-clinical research for its involvement in:

• Growth Hormone Release Modeling:
  Studying endogenous GH secretion patterns initiated through GHRH receptor activation.

• Hypothalamic–Pituitary Axis Research:
  Evaluating peptide-mediated communication between hypothalamic signaling and pituitary response.

• Endocrine Feedback Studies:
  Modeling regulatory loops involved in hormone release and suppression mechanisms.

• Comparative Peptide Analysis:
  Used alongside GHRPs (GHRP-2, GHRP-6, Ipamorelin) to contrast GHRH-based vs ghrelin-based signaling.

• Peptide Stability and Kinetics:
  Research into short-acting peptide dynamics and degradation profiles.

Key Features

• Peptide Class: Growth Hormone–Releasing Hormone (GHRH 1-29) analog

• Amino Acid Sequence: Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂

• Molecular Weight: ~3357 Da

• Form: Lyophilized powder for reconstitution

• Purity: ≥98% research-grade

• Laboratory Stability: Maintains integrity when stored under recommended cold-storage conditions

Potential Applications

Researchers may explore Sermorelin in studies involving:

• Growth hormone signaling dynamics

• Endocrine axis regulation

• GHRH receptor activation models

• Hormonal feedback loop analysis

• Comparative endocrine peptide research

Specifications

This product is supplied in a sterile, tamper-evident vial to preserve molecular integrity and purity. Reconstitution should be performed using appropriate laboratory-grade diluents and standard peptide-handling protocols. Proper refrigerated or frozen storage is recommended to maintain stability.